Anti-VEGF Therapy and Diabetic Retinopathy

Inhibition of vascular endothelial growth factor (anti- VEGF therapy) may slow or stop progression of diabetic retinopathy (DR) among patients with diabetic macular edema (DME). According to results from two phase 3 clinical trials, a...

Full Story →